PUBLICACIÓN

Dihydrofolate reductase genetic polymorphisms affect methotrexate dose requirements in pediatric patients with acute lymphoblastic leukemia on maintenance therapy

ACCEDER A LA PUBLICACIÓN: Scopus Orcid

Gervasini G., De Murillo S.G., Jimenez M., De La Maya M.D., Vagace J.M.

2017 Journal of Pediatric Hematology/Oncology

Hematology (Q3), Oncology (Q3), Pediatrics, Perinatology and Child Health (Q2)

JCR: 1.06

SJR: 0.459


CITAS

10

DOI

10.1097/mph.0000000000000908

EID

2-s2.0-85024502614

ISSN

1077-4114

EISSN

1536-3678

BIBTEX

@article{PMID:28719513, title = {Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy.}, author = {Gervasini G and de Murillo SG and Jiménez M and de la Maya MD and Vagace JM}, doi = {10.1097/mph.0000000000000908}, journal = {Journal of pediatric hematology/oncology}, month = {11}, year = {2017} }


AUTORES DE LA UEX